Compare AMR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMR | ATRC |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2017 | 2005 |
| Metric | AMR | ATRC |
|---|---|---|
| Price | $142.96 | $34.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $181.50 | $51.17 |
| AVG Volume (30 Days) | 195.4K | ★ 991.1K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,129,481,000.00 | $201,630,000.00 |
| Revenue This Year | $15.05 | $15.27 |
| Revenue Next Year | $14.78 | $12.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $113.00 | $25.36 |
| 52 Week High | $253.82 | $43.18 |
| Indicator | AMR | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 33.85 | 58.67 |
| Support Level | N/A | $30.77 |
| Resistance Level | $156.88 | $34.38 |
| Average True Range (ATR) | 5.91 | 1.32 |
| MACD | 0.51 | -0.20 |
| Stochastic Oscillator | 29.82 | 43.63 |
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.